8/13/2019 12:14:51 PM - Gaped up 8/07/19 on M&A news. Quarterly earnings have been below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong.
8/12/2019 1:01:10 PM - Gaped up 8/07/19 on M&A news. Quarterly earnings have been below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong.
8/9/2019 1:19:29 PM - Gaped up 8/07/19. Quarterly earnings have been below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong.
8/4/2017 12:08:47 PM - Undercut its 50 DMA line ($58.27) after gapping down today, retreating from its all-time high. Reported Jun '17 quarterly earnings +12% on +13% sales revenues. Prior quarterly earnings increases were below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong.
6/21/2017 1:32:33 PM - Consolidating near its 52-week and all-time highs. Reported Mar '17 quarterly earnings +36% on +11% sales revenues. Prior quarterly earnings increases were below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong.
2/6/2017 12:17:31 PM - Retreating today after gapping up and hitting new 52-week and all-time highs on the prior session. Reported Dec '16 quarterly earnings +22% on +14% sales revenues. Prior quarterly earnings increases were also below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong.
7/26/2016 12:23:07 PM - Retreating after wedging to new 52-week highs, and today's big volume-driven loss is testing its 50 DMA line. Rallied after reporting Mar '16 quarterly earnings +72% on +22% sales revenues. Prior quarterly and annual earnings (C and A criteria) history has been strong.
6/1/2016 12:23:21 PM - Held its ground since last noted with caution in the 5/02/16 mid-day report - "Rebounding toward its 52-week high after a deep slump below its 200 DMA line, yet it still faces resistance due to overhead supply up through the $55 level. Rallying after reporting Mar '16 quarterly earnings +72% on +22% sales revenues. Prior quarterly and annual earnings (C and A criteria) history has been strong."
5/2/2016 12:25:32 PM - Rebounding toward its 52-week high after a deep slump below its 200 DMA line, yet it still faces resistance due to overhead supply up through the $55 level. Rallying after reporting Mar '16 quarterly earnings +72% on +22% sales revenues. Prior quarterly and annual earnings (C and A criteria) history has been strong.
4/29/2016 12:25:08 PM - Rallying today after Mar '16 quarterly earnings news. Prior quarterly and annual earnings (C and A criteria) history has been strong. Rebounding toward its 52-week high after a deep slump below its 200 DMA line since last noted with caution in the 11/30/15 mid-day report.
11/30/2015 1:11:36 PM - Touched a new 52-week high today then reversed into the red. Last noted with caution in the 11/03/15 mid-day report - "Reported earnings +43% on +14% sales for the Sep '15 quarter, its 4th consecutive quarterly earnings comparison above the +25% minimum earnings guideline (C criteria). Deceleration in is sales revenues growth rate is a fundamental concern as they rose by +26%, +17%, and +9% over the Dec '14, Mar and Jun '15 quarters, respectively."
11/3/2015 12:18:13 PM - Clearing prior resistance and rallying toward its 52-week high with today's 3rd consecutive gain. Reported earnings +43% on +14% sales for the Sep '15 quarter, its 4th consecutive quarterly earnings comparison above the +25% minimum earnings guideline (C criteria). Deceleration in is sales revenues growth rate is a fundamental concern as they rose by +26%, +17%, and +9% over the Dec '14, Mar and Jun '15 quarters, respectively.
8/6/2015 12:26:22 PM - Extended from any sound base and abruptly retreating from its 52-week high with today's considerable volume-driven loss. Reported earnings +80% on +9% sales for the Jun '15 quarter, its 3rd consecutive quarterly earnings comparison above the +25% minimum earnings guideline (C criteria). Deceleration in is sales revenues growth rate is a fundamental concern as they rose by +26%, +17%, and +9% over the Dec '14, Mar and Jun '15 quarters, respectively.
7/27/2015 12:17:10 PM - Extended from any sound base and pulling back from its 52-week high with today's 3rd consecutive loss on ever-increasing volume. Reported earnings +383% on +17% sales for the Mar '15 quarter. Prior quarterly sales revenues and earnings comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria).
6/16/2015 12:15:26 PM - Found support near its 50 DMA line during its ongoing ascent since a considerable "breakaway gap" on 2/06/15. Reported earnings +383% on +17% sales for the Mar '15 quarter. Prior quarterly sales revenues and earnings comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria).
5/4/2015 12:28:37 PM - Finding support at its 50 DMA line ($37.77) today after volume-driven losses. Since a considerable "breakaway gap" on 2/06/15 it made gradual progress. Reported earnings +383% on +17% sales for the Mar '15 quarter. Prior quarterly sales revenues and earnings comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria).
5/1/2015 12:15:20 PM - Undercut its 50 DMA line ($37.80) with early losses today then rebounded near that important short term average. Since a considerable "breakaway gap" on 2/06/15 it made gradual progress. Reported earnings +383% on +17% sales for the Mar '15 quarter. Prior quarterly sales revenues and earnings comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria).
4/6/2015 12:31:50 PM - Hitting another new 52-week high with a volume-driven gain, getting more extended from any sound base. Made steady progress while staying well above its 50 DMA line since a considerable "breakaway gap" on 2/06/15. Prior mid-day reports cautioned members - "Reported earnings +78% on +26% sales for the Dec '14 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria)."
4/2/2015 12:41:33 PM - Making its 3rd consecutive mid-day report appearance and getting more extended from any sound base with today's gain. Made steady progress while staying well above its 50 DMA line since a considerable "breakaway gap" on 2/06/15. Prior mid-day reports cautioned members - "Reported earnings +78% on +26% sales for the Dec '14 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria)."
4/1/2015 12:23:52 PM - Making its second consecutive mid-day report appearance, pulling back today following a big volume-driven gain on the prior session. It is extended from any sound base and made steady progress while staying well above its 50 DMA line since a considerable "breakaway gap" on 2/06/15. Prior mid-day reports cautioned members - "Reported earnings +78% on +26% sales for the Dec '14 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria)."
3/31/2015 12:30:04 PM - Extended from any sound base. Made progress and stayed above the 50 DMA line since a considerable "breakaway gap" on 2/06/15. Prior mid-day reports cautioned members - "Reported earnings +78% on +26% sales for the Dec '14 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria)."
3/26/2015 12:23:39 PM - Managed a "positive reversal" from today's early lows. There was a considerable "breakaway gap" on 2/06/15. Prior mid-day reports cautioned members - "Reported earnings +78% on +26% sales for the Dec '14 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria)."
3/11/2015 12:24:50 PM - Perched at its 52-week high today, making gradual progress following a considerable "breakaway gap" on 2/06/15. The 2/13/15 mid-day report cautioned members - "Reported earnings +78% on +26% sales for the Dec '14 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria)."
2/13/2015 12:30:03 PM - Hitting new 52-week highs with additional volume-driven gains following a considerable "breakaway gap" on 2/06/15. Reported earnings +78% on +26% sales for the Dec '14 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria).
2/12/2015 12:13:04 PM - Hitting new 52-week highs with additional volume-driven gains following a considerable "breakaway gap" on 2/06/15. Reported earnings +78% on +26% sales for the Dec '14 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria).
2/10/2015 12:19:17 PM - Holding its ground near its 52-week high following a considerable "breakaway gap" on 2/06/15. Reported earnings +78% on +26% sales for the Dec '14 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria).
2/9/2015 12:15:17 PM - Perched at its 52-week high today following a considerable "breakaway gap" on the prior session. Reported earnings +78% on +26% sales for the Dec '14 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). Last noted with caution in the 2/20/14 mid-day report - "Prior quarterly and annual earnings (A criteria) history has not been strong and steady."
2/20/2014 12:14:05 PM - Perched at its 52-week high with today's 6th consecutive gain. Reported earnings +25% on +47% sales for the Dec '13 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). Found support at its 200 DMA line on pullbacks then continued higher since last noted with caution in the 6/28/13 mid-day report - "Prior quarterly and annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
6/28/2013 12:13:25 PM - Touched a new 52-week high since last noted in the 6/05/13 mid-day report, however gains lacked great volume conviction. Reported earnings +13% on +7% sales for the Mar '13 quarter, below the +25% minimum earnings guideline (C criteria). Found support at its 200 DMA line then rebounded following its deep consolidation from highs hit when noted in the 10/16/12 mid-day report with caution - "This Medical - Products firm's sales revenues and earnings improved in the Mar and Jun '12 quarters. Prior quarterly and annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
6/5/2013 12:13:32 PM - Reported earnings +13% on +7% sales for the Mar '13 quarter, below the +25% minimum earnings guideline (C criteria). Perched within striking distance of its 52-week high now, it found support at its 200 DMA line then rebounded following its deep consolidation from highs hit when last noted in the 10/16/12 mid-day report with caution - "This Medical - Products firm's sales revenues and earnings improved in the Mar and Jun '12 quarters. Prior quarterly and annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
10/16/2012 11:56:57 AM - Hitting another new 52-week high today. Found support at its 50 DMA line when recently consolidating. Prior mid-day reports noted - "This Medical - Products firm's sales revenues and earnings improved in the Mar and Jun '12 quarters. Prior quarterly and annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
10/11/2012 12:02:34 PM - Hitting a new 52-week high today with higher volume behind a solid gain. Found support at its 50 DMA line when consolidating since last noted in the 9/21/12 mid-day report - "This Medical - Products firm's sales revenues and earnings improved in the Mar and Jun '12 quarters. Prior quarterly and annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
9/21/2012 12:06:10 PM - Poised for a best close of the year with a volume-driven gain near its 52-week high today. This Medical - Products firm's sales revenues and earnings improved in the Mar and Jun '12 quarters. Prior quarterly and annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied.
9/10/2012 11:52:07 AM - Hitting a new 52-week high today. Held its ground in a tight range since noted in the 8/15/12 mid-day report - "This low-priced Medical - Products firm found support near its 200 DMA line during a deep consolidation after noted in the 1/18/12 mid-day report, then worked its way higher in recent months with above average volume behind gains. Sales revenues and earnings improved in the Mar and Jun '12 quarters, but prior mid-day reports noted - 'Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied.'"
9/6/2012 12:12:55 PM - Trading near its 52-week high today. Held its ground in a tight range since noted in the 8/15/12 mid-day report - "This low-priced Medical - Products firm found support near its 200 DMA line during a deep consolidation after noted in the 1/18/12 mid-day report, then worked its way higher in recent months with above average volume behind gains. Sales revenues and earnings improved in the Mar and Jun '12 quarters, but prior mid-day reports noted - 'Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied.'"
8/29/2012 11:58:51 AM - Hovering near its 52-week high today, holding its ground in a tight range with volume totals cooling since last noted in the 8/15/12 mid-day report - "This low-priced Medical - Products firm found support near its 200 DMA line during a deep consolidation after noted in the 1/18/12 mid-day report, then worked its way higher in recent months with above average volume behind gains. Sales revenues and earnings improved in the Mar and Jun '12 quarters, but prior mid-day reports noted - 'Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied.'"
8/15/2012 11:54:36 AM - Hit another new 52-week high with today's 3rd consecutive volume-driven gain after holding its ground stubbornly following its considerable 8/02/12 gain. This low-priced Medical - Products firm found support near its 200 DMA line during a deep consolidation after noted in the 1/18/12 mid-day report, then worked its way higher in recent months with above average volume behind gains. Sales revenues and earnings improved in the Mar and Jun '12 quarters, but prior mid-day reports noted - "Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
8/14/2012 12:13:02 PM - Hitting another new 52-week high today after holding its ground stubbornly following its considerable 8/02/12 gain with above average volume. This low-priced Medical - Products firm found support near its 200 DMA line during a deep consolidation after noted in the 1/18/12 mid-day report, then worked its way higher in recent months with above average volume behind gains. Sales revenues and earnings improved in the Mar and Jun '12 quarters, but prior mid-day reports noted - "Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
8/10/2012 12:12:43 PM - Still holding its ground at its 52-week high after a considerable 8/02/12 gain with above average volume. This low-priced Medical - Products firm found support near its 200 DMA line during its consolidation since last noted in the 1/18/12 mid-day report then worked its way higher in recent months with above average volume behind gains. Sales revenues and earnings improved in the Mar and Jun '12 quarters, but prior mid-day reports noted - "Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
8/9/2012 12:02:40 PM - Still holding its ground at its 52-week high after a considerable 8/02/12 gain with above average volume. This low-priced Medical - Products firm found support near its 200 DMA line during its consolidation since last noted in the 1/18/12 mid-day report then worked its way higher in recent months with above average volume behind gains. Sales revenues and earnings improved in the Mar and Jun '12 quarters, but prior mid-day reports noted - "Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
8/7/2012 12:10:28 PM - Holding its ground at its 52-week high after a considerable 8/02/12 gain with above average volume. This low-priced Medical - Products firm found support near its 200 DMA line during its consolidation since last noted in the 1/18/12 mid-day report then worked its way higher in recent months with above average volume behind gains. Sales revenues and earnings improved in the Mar and Jun '12 quarters, but prior mid-day reports noted - "Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
8/6/2012 12:02:55 PM - Holding its ground at its 52-week high after a considerable 8/02/12 gain with above average volume. This low-priced Medical - Products firm found support near its 200 DMA line during its consolidation since last noted in the 1/18/12 mid-day report then worked its way higher in recent months with above average volume behind gains. Sales revenues and earnings improved in the Mar and Jun '12 quarters, but prior mid-day reports noted - "Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
1/18/2012 12:24:33 PM - Gain today has it hitting yet another new 52-week high with above average volume. This low-priced Medical - Products firm steadily worked its way higher with above average volume behind its small gains while repeatedly noted in prior mid-day reports- "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
1/10/2012 11:59:20 AM - Holding its ground today after spiking to a new 52-week high with a volume-driven gain on 1/06/12. This low-priced Medical - Products firm steadily worked its way higher with above average volume behind its small gains, while repeatedly noted in prior mid-day reports- "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
1/9/2012 12:39:50 PM - Holding its ground today after spiking to a new 52-week high with a volume-driven gain on the prior session. This low-priced Medical - Products firm steadily worked its way higher with above average volume behind its small gains, while repeatedly noted in prior mid-day reports- "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
12/23/2011 12:19:31 PM - Perched near its 52-week high still stubbornly holding its ground after a noted spurt of 13 gains in the span of 15 sessions. This low-priced Medical - Products firm steadily worked its way higher with above average volume behind its small gains, while repeatedly noted in prior mid-day reports- "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
12/20/2011 12:33:28 PM - Perched near its 52-week high after a noted spurt of 13 gains in the span of 15 sessions. This low-priced Medical - Products firm has steadily worked its way higher with above average volume behind its small gains, and it stubbornly held its ground while repeatedly noted in prior mid-day reports- "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
12/16/2011 12:35:13 PM - Perched at its 52-week high today while on track for its 13th gain in the span of 15 sessions. This low-priced Medical - Products firm has steadily worked its way higher with above average volume behind its small gains, and it stubbornly held its ground while repeatedly noted in prior mid-day reports- "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
12/15/2011 12:36:42 PM - Touched another new 52-week high today while on track for its 12th gain in the span of 14 sessions. This low-priced Medical - Products firm has steadily worked its way higher with above average volume behind its small gains, and it stubbornly held its ground while repeatedly noted in prior mid-day reports- "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
12/13/2011 12:18:24 PM - Hitting another new 52-week high today. This low-priced Medical - products firm has steadily worked its way higher and stubbornly held its ground while it was repeatedly noted in prior mid-day reports- "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
12/12/2011 12:09:03 PM - Perched at its 52-week high today, still stubbornly holding its ground. This low-priced Medical - products firm was noted in prior mid-day reports- "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
12/8/2011 12:26:54 PM - Perched at its 52-week high today, stubbornly holding its ground. This low-priced Medical - products firm was noted in prior mid-day reports- "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
12/7/2011 11:57:06 AM - Perched at its 52-week high. This low-priced Medical - products firm was noted in prior mid-day reports- "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
12/5/2011 12:01:00 PM - Touched another new 52-week high today. This low-priced Medical - products firm was last noted in the 11/30/11 mid-day report- "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
11/30/2011 12:08:51 PM - Touched a new 52-week high today with a 3rd consecutive volume-driven gain. This low-priced stock was noted in prior mid-day reports - "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
11/29/2011 12:10:31 PM - Rising within striking distance of its 52-week high with a second consecutive volume-driven gain today. Prior mid-day reports noted - "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
11/28/2011 12:19:31 PM - Rising within striking distance of its 52-week high with a gap up and volume-driven gain today. Prior mid-day reports noted - "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
11/23/2011 12:20:55 PM - Rebounded toward its 52-week high with a volume-driven gain on the prior session following 2 consecutive losses with above average volume. The 11/18/11 mid-day report noted - "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
11/22/2011 12:09:43 PM - Rebounding toward its 52-week high today following 2 consecutive losses with above average volume. The 11/18/11 mid-day report noted - "Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
11/18/2011 12:14:22 PM - Recently inching toward its 52-week high with small gains backed by above average volume. Sales revenues increases showed modest acceleration in recent quarterly comparisons while earnings improved. Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied.